Skip to main content

and
  1. Article

    Open Access

    Multiple antibody specificities (gp41, V1V2, and V3) elicited in the phase II multiclade (A, B, C) HIV-1 DNA prime, rAd5 boost vaccine trial

    WB Williams, K Jones, A Krambrink, D Grove, P Liu, NL Yates, MA Moody in Retrovirology (2012)

  2. Article

    Open Access

    E-DNA IM or ID delivery prime enhances antibody and T cell responses following recombinant gp120 env boost

    NA Hutnick, M Karuppiah, J Pollara, J Yan, DJ Myles, K Broderick, M Morrow in Retrovirology (2012)

  3. Article

    Open Access

    Antibody-dependent cellular cytotoxicity-mediating antibodies from an HIV-1 vaccine efficacy trial preferentially use the VH1 gene family

    M Bonsignori, J Pollara, MA Moody, TB Kepler, X Chen, TC Gurley, DM Kozink in Retrovirology (2012)

  4. Article

    Open Access

    Vaccine-induced ADCC-mediating antibodies target unique and overlap** envelope epitopes

    J Pollara, M Bonsignori, M Moody, M Alam, H Liao, K Hwang, J Pickeral in Retrovirology (2012)